New York State Common Retirement Fund lowered its holdings in Colgate-Palmolive (NYSE:CL) by 1.2% in the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,660,656 shares of the company’s stock after selling 31,265 shares during the period. New York State Common Retirement Fund’s holdings in Colgate-Palmolive were worth $190,716,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also modified their holdings of the stock. BlackRock Inc. boosted its holdings in Colgate-Palmolive by 3.0% in the first quarter. BlackRock Inc. now owns 53,953,299 shares of the company’s stock valued at $3,867,373,000 after purchasing an additional 1,592,608 shares during the last quarter. Wells Fargo & Company MN boosted its holdings in Colgate-Palmolive by 11.3% in the first quarter. Wells Fargo & Company MN now owns 9,886,686 shares of the company’s stock valued at $708,678,000 after purchasing an additional 1,003,612 shares during the last quarter. Geode Capital Management LLC boosted its holdings in Colgate-Palmolive by 2.1% in the fourth quarter. Geode Capital Management LLC now owns 8,975,479 shares of the company’s stock valued at $675,751,000 after purchasing an additional 188,455 shares during the last quarter. First Eagle Investment Management LLC boosted its holdings in Colgate-Palmolive by 45.7% in the first quarter. First Eagle Investment Management LLC now owns 7,830,595 shares of the company’s stock valued at $561,297,000 after purchasing an additional 2,455,839 shares during the last quarter. Finally, OppenheimerFunds Inc. boosted its holdings in Colgate-Palmolive by 2.8% in the fourth quarter. OppenheimerFunds Inc. now owns 6,173,804 shares of the company’s stock valued at $465,813,000 after purchasing an additional 166,537 shares during the last quarter. 73.30% of the stock is owned by hedge funds and other institutional investors.
A number of research analysts recently commented on CL shares. Zacks Investment Research downgraded Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Friday, April 6th. Morgan Stanley downgraded Colgate-Palmolive from an “overweight” rating to an “equal weight” rating in a report on Monday, April 30th. ValuEngine downgraded Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Wednesday, May 2nd. Stifel Nicolaus reaffirmed a “hold” rating and set a $75.00 target price on shares of Colgate-Palmolive in a report on Wednesday, April 18th. Finally, Citigroup reduced their target price on Colgate-Palmolive from $80.00 to $73.00 and set a “neutral” rating on the stock in a report on Tuesday, May 1st. Four investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and four have assigned a buy rating to the stock. Colgate-Palmolive presently has an average rating of “Hold” and a consensus target price of $76.38.
In related news, Vice Chairman Franck J. Moison sold 80,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 15th. The stock was sold at an average price of $61.75, for a total value of $4,940,000.00. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Daniel B. Marsili sold 19,500 shares of the firm’s stock in a transaction that occurred on Monday, April 16th. The stock was sold at an average price of $71.85, for a total value of $1,401,075.00. Following the completion of the sale, the insider now directly owns 77,935 shares in the company, valued at approximately $5,599,629.75. The disclosure for this sale can be found here. In the last three months, insiders sold 142,079 shares of company stock worth $8,981,683. Company insiders own 1.02% of the company’s stock.
Colgate-Palmolive opened at $62.49 on Friday, MarketBeat reports. The company has a debt-to-equity ratio of 64.85, a quick ratio of 0.75 and a current ratio of 1.08. Colgate-Palmolive has a 52 week low of $61.28 and a 52 week high of $77.91. The company has a market cap of $54.71 billion, a price-to-earnings ratio of 21.77, a PEG ratio of 2.48 and a beta of 0.75.
Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, April 27th. The company reported $0.74 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.73 by $0.01. The business had revenue of $4 billion for the quarter, compared to the consensus estimate of $4.01 billion. Colgate-Palmolive had a return on equity of 1,486.69% and a net margin of 13.30%. The business’s revenue was up 6.4% on a year-over-year basis. During the same quarter last year, the business posted $0.67 EPS. research analysts forecast that Colgate-Palmolive will post 3.17 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, May 15th. Investors of record on Friday, April 20th were issued a $0.42 dividend. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.40. The ex-dividend date of this dividend was Thursday, April 19th. This represents a $1.68 annualized dividend and a dividend yield of 2.69%. Colgate-Palmolive’s dividend payout ratio (DPR) is 58.54%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.